Oncolys Biopharma Inc. (4588)
Market Closed
5 Oct, 06:25 AM
JPX JPX Primary 
TWSE ¥
6,490. 00
+510
+8.5284%
¥
29.17B Market Cap
- P/E Ratio
- Div Yield
1.47M Volume
- Eps
¥ 5,980
Previous Close Want to track 4588 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oncolys Biopharma Inc. (4588) Statistics
Valuation metrics
Market Cap 29.17B
Enterprise value 172.68B
Trailing P/E (ttm) -108.62
Forward P/E -27.21
PEG ratio -1.94
Price/Sales (ttm) 347.49
Price/Book (mrq) 53.69
Enterprise Value/Revenue 343.24
Enterprise Value/EBITDA -114.6
Overview
Shares outstanding 29.28M
Float 24.02M
Shares short -
% Held by insiders 0.12%
% Held by institutions 0.07%
Average volume (10 days) 1.25M
Average volume (90 days) 1.35M
Price summary
52-Week low 668
52-Week high 6,850
Beta 1.16
50-Day moving average 5,225.18
200-Day moving average 3,241.09
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -3%
Operating margin -3.03%
Operational effectiveness
Return on assets -0.33%
Return on equity -0.48%
Income Statement
Revenue (ttm) 28.55M
Revenue per share (ttm) 17.17
Quarterly revenue growth (yoy) -
Gross profit (ttm) 28.55M
EBITDA -2.03B
Net income to common (ttm) -2.06B
Diluted EPS (ttm) -51.45
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.35B
Total cash per share (mrq) 108.79
Total debt (mrq) 339.24M
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 3.91%
Book value per share (mrq) 111.2
Cash Flow
Cash flow statement -2.11B
Levered free cash flow (LFCF) -2.06B
2026 © Marketlog. All Rights Reserved.
